News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
517,035 Results
Type
Article (13954)
Company Profile (156)
Press Release (502924)
Multimedia
Podcasts (58)
Webinars (8)
Section
Business (173266)
Career Advice (348)
Deals (26649)
Drug Delivery (28)
Drug Development (58992)
Employer Resources (24)
FDA (10790)
Job Trends (9429)
News (251796)
Policy (21329)
Tag
2025 Best Places to Work (6)
2026 Best Places to Work (13)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
40 Under 40 (1)
Academia (815)
Accelerated approval (37)
ADA (19)
Adcomms (11)
Allergies (109)
Alliances (35104)
ALS (125)
Alzheimer's disease (1093)
Antibody-drug conjugate (ADC) (354)
Approvals (11483)
Artificial intelligence (411)
ASCO (171)
Autoimmune disease (291)
Automation (36)
Bankruptcy (272)
Belgium (5)
Best Places to Work (7641)
BIO (40)
Biologics (69)
BIOSECURE Act (3)
Biosimilars (134)
BioSpace Insights (31)
Biotechnology (91)
Bispecific (32)
Bladder cancer (153)
Brain cancer (44)
Breast cancer (570)
Cancer (4423)
Cardiovascular disease (266)
Career advice (292)
Career pathing (2)
CAR-T (218)
CDC (66)
CDMO (103)
Celiac Disease (3)
Cell-line development (1)
Cell therapy (595)
Cervical cancer (44)
Clinical research (52604)
Collaboration (1492)
Commercialization (39)
Company closure (2)
Compensation (1678)
Complete response letters (42)
COVID-19 (2467)
CRISPR (86)
CRO (1)
C-suite (938)
Cystic fibrosis (96)
Data (7097)
Denatured (8)
Depression (112)
Dermatology (119)
Diabetes (407)
Diagnostics (4486)
Digital health (46)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (199)
Drug pricing (27)
Drug shortages (6)
Duchenne muscular dystrophy (194)
Earnings (76178)
Editorial (32)
Employer branding (3)
Employer resources (23)
ESMO (257)
Events (91936)
Executive appointments (789)
Eye disease (11)
FDA (14036)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (22)
Frontotemporal dementia (27)
Funding (1098)
Gene editing (163)
Generative AI (20)
Gene therapy (412)
GLP-1 (400)
Government (2576)
Grass and pollen (3)
Guidances (306)
Healthcare (10434)
Hematology (123)
HIV (68)
Huntington's disease (31)
Idiopathic pulmonary fibrosis (6)
IgA nephropathy (88)
Immunology and inflammation (145)
Immuno-oncology (86)
Indications (200)
Infectious disease (2835)
Inflammatory bowel disease (163)
Inflation Reduction Act (4)
Influenza (149)
Intellectual property (285)
Interviews (45)
IPO (12765)
IRA (7)
Job creations (2147)
Job search strategy (277)
JPM (13)
Kidney cancer (19)
Kidney disease (95)
Labor market (7)
Layoffs (145)
Leadership (5)
Legal (5497)
Licensing (73)
Liver cancer (47)
Longevity (28)
Lung cancer (612)
Lung diease (11)
Lymphoma (310)
Machine learning (30)
Management (9)
Manufacturing (767)
Marketing (26)
MASH (133)
Medical affairs (3)
Medical device (8896)
Medtech (9099)
Mergers & acquisitions (15083)
Metabolic disorders (884)
mRNA (260)
Multiple sclerosis (142)
Multispecific (4)
NASH (4)
Netherlands (6)
Neurodegenerative disease (264)
Neuropsychiatric disorders (45)
Neuroscience (2122)
Neurotech (2)
NextGen: Class of 2026 (3312)
Non-profit (1095)
Now hiring (9)
Obesity (307)
Opinion (53)
Ovarian cancer (191)
Pain (199)
Pancreatic cancer (251)
Parkinson's disease (227)
Partnered (14)
Patents (570)
Patient advocacy (3)
Patient recruitment (561)
Patient selection (60)
Peanut (38)
People (43443)
Peptides (26)
Pharmaceutical (31)
Pharmacy benefit managers (11)
Phase 1 (17142)
Phase 2 (23377)
Phase 3 (16315)
Pipeline (9592)
Policy (148)
Postmarket research (1760)
Preclinical (7155)
Press Release (43)
Prostate cancer (215)
Psychedelics (26)
Radiopharmaceuticals (208)
Rare diseases (714)
Real estate (3312)
Recruiting (9)
Regenerative medicine (18)
Regulatory (17535)
Reports (32)
Research institute (913)
Resumes & cover letters (47)
Rett syndrome (48)
RNA editing (18)
RSV (98)
Schizophrenia (115)
Series A (185)
Series B (133)
Service/supplier (5)
Sickle cell disease (75)
Special edition (3)
Spinal muscular atrophy (95)
Sponsored (10)
Startups (2175)
Stem cells (3)
Stomach cancer (3)
Substance use disorders (17)
Supply chain (72)
Switzerland (3)
Tariffs (21)
The Weekly (48)
Vaccines (1442)
Venture capital (32)
Weight loss (120)
Wet AMD (3)
Women's health (103)
Date
Today (115)
Last 7 days (579)
Last 30 days (2574)
Last 365 days (20265)
2026 (18394)
2025 (20372)
2024 (24167)
2023 (27888)
2022 (36999)
2021 (40561)
2020 (36438)
2019 (24598)
2018 (18589)
2017 (19743)
2016 (18973)
2015 (25322)
2014 (22557)
2013 (18910)
2012 (21044)
2011 (21331)
2010 (21187)
Location
Africa (370)
Alabama (83)
Alaska (2)
Arizona (337)
Arkansas (12)
Asia (21036)
Australia (2646)
California (13597)
Canada (3538)
China (692)
Colorado (578)
Connecticut (477)
Delaware (253)
Europe (32236)
Florida (2021)
Georgia (439)
Hawaii (3)
Idaho (46)
Illinois (835)
India (90)
Indiana (396)
Iowa (22)
Japan (529)
Kansas (114)
Kentucky (40)
Louisiana (31)
Maine (28)
Maryland (1505)
Massachusetts (8946)
Michigan (332)
Minnesota (635)
Mississippi (6)
Missouri (89)
Montana (28)
Nebraska (12)
Nevada (144)
New Hampshire (62)
New Jersey (3169)
New Mexico (13)
New York (3187)
North Carolina (1447)
North Dakota (11)
Northern California (6917)
Ohio (317)
Oklahoma (15)
Oregon (17)
Pennsylvania (2587)
Puerto Rico (26)
Rhode Island (32)
South America (482)
South Carolina (82)
South Dakota (1)
Southern California (5677)
Tennessee (139)
Texas (2265)
United States (44569)
Utah (412)
Vermont (1)
Virginia (182)
Washington D.C. (43)
Washington State (1042)
West Virginia (2)
Wisconsin (85)
Wyoming (1)
517,035 Results for "meissa vaccines inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Earnings
Moderna enjoys stable vaccine sales thanks to global COVID uptake
While Moderna preps an entry to the oncology market next year with a personalized cancer vaccine, COVID sales are holding steady with several other vaccine launches underway around the world.
November 6, 2026
·
4 min read
·
Annalee Armstrong
Earnings
GSK vaccine sales miss expectations amid falling demand from adults
With pressure on GSK’s vaccine business, analysts predict the U.K. pharma will face challenges as it prepares for the loss of exclusivity on a key product.
October 28, 2026
·
2 min read
·
Nick Paul Taylor
Cancer
Sellas’ cancer vaccine slashes death risk by 41% in late-stage AML study
Sellas Life Sciences’ investigational cancer vaccine prolonged median overall survival by over nine months compared to standard of care in a Phase 3 trial for difficult-to-treat acute myeloid leukemia.
November 17, 2026
·
2 min read
·
Gabrielle Masson
Vaccines
Pfizer eyes Europe first for Lyme vaccine as prevalence rises in US
Since Pfizer already owns a tick-borne encephalitis franchise in Europe, the region is a natural first step for the pharma’s upcoming Lyme disease vaccine.
November 4, 2026
·
1 min read
·
Annalee Armstrong
Manufacturing
Merck, Moderna serve 99% of trial patients with mRNA vaccine as personalized shots near market
Personalized cancer vaccines are getting closer to market. Merck and Moderna just showed successful manufacturing in a large Phase 3 trial, proving they can deliver the goods.
November 6, 2026
·
2 min read
·
Annalee Armstrong
Cancer
ESMO 2026: Merck, Moderna shares fall as cancer vaccine disappoints after data leak
A combination of the personalized cancer vaccine intismeran autogene and Merck’s Keytruda just barely cleared analysts’ expectations for recurrence-free survival, leaving questions as to its applicability to tumor types beyond melanoma.
October 22, 2026
·
5 min read
·
Annalee Armstrong
Biotech Bay
Meissa Vaccines Announces Positive Clinical Data for the First RSV Vaccine Designed to Protect Infants and Toddlers
Meissa Vaccines (“Meissa”), a clinical-stage biotechnology company developing vaccines to prevent viral respiratory infections, today announced positive safety and immunogenicity data for MV-012-968, Meissa’s intranasal live attenuated RSV vaccine candidate, from a clinical study in RSV-naïve (seronegative) participants between the ages of six and 36 months.
August 8, 2023
·
4 min read
Cancer
ESMO 2026: Analysts warm to Merck, Moderna’s cancer vaccine after frustrating data leak
After sitting through the full presentation on the Phase 3 INTerpath-001 trial at the ESMO Congress over the weekend, analysts are more keen on the personalized mRNA cancer vaccine data that last week spurred a stock selloff for both partners.
October 26, 2026
·
3 min read
·
Annalee Armstrong
Layoffs
GSK lays off 650 staffers amid closure of German vaccine manufacturing site
GSK is consolidating its vaccine manufacturing operations to one site—located in Canada—amid the pharma’s recent $2.5 billion savings campaign.
September 15, 2026
·
2 min read
·
Tristan Manalac
Cancer
5 drugmakers chasing Merck and Moderna in the cancer vaccine race
Following their blowout win in melanoma last month, Merck and Moderna are leading the way among a new crop of personalized cancer vaccines. Here are five companies with similar therapies hoping to break through where others have previously failed.
September 14, 2026
·
9 min read
·
Tristan Manalac
1 of 51,704
Next